Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 9 | BES2005 | Next issue

24th Joint Meeting of the British Endocrine Societies

Clinical Management Workshops

Clinical Management Workshop 1: Diagnosis and management of steroid deficiency

ea0009s38 | Clinical Management Workshop 1: Diagnosis and management of steroid deficiency | BES2005

Why is the management of corticosteroid deficiency still controversial?

Lightman S , #

Whereas it was previously accepted that patients needed between 20 and 30mg of hydrocortisone daily, current estimates are much lower at approximately 10mg per day. The next question - which appears uncontroversial - is the choice of drug. This is universally accepted as being hydrocortisone. But is it? The adrenal glands secrete both cortisol and cortisone and there is now increasing evidence that 11betaHSD-1 can, in a tissue-specific manner, convert cortisone to cortisol. Th...

ea0009s39 | Clinical Management Workshop 1: Diagnosis and management of steroid deficiency | BES2005

Diagnosing the suppressed adrenal

Stewart P

Adrenal insufficiency may occur because of primary failure of the adrenal cortex but can also arise through a secondary failure of ACTH drive to the adrenal. 'Endogenous' suppression of the adrenal cortex may occur in patients with structural abnormalities affecting the hypothalamus/pituitary and in other patients with deficiency of pituitary ACTH secretion and action including those recovering from successful treatment of Cushing's syndromes. 'Exogenous' suppression is found ...

ea0009s40 | Clinical Management Workshop 1: Diagnosis and management of steroid deficiency | BES2005

Glucocorticoid resistance

Lamberts S

Generalized Glucocorticoid Resistance (GR) is rare. Only about 30 patients and (asymptomatic) family members with GR have been described. The molecular basis of GR has been elucidated in nine patients and affected family members: mutations in the hormone binding domain of the glucocorticoid receptor gene were responsible for the clinical manifestations of GR, while in one individual a mutation in the DNA-binding domain was observed. Clinical presentation varied, including hypo...